Authors:
Russo, P
Ottoboni, C
Crippa, A
Riou, JF
O'Connor, PM
Citation: P. Russo et al., RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G(0)/G(1) arrest only in serum starved cells, INT J ONCOL, 18(4), 2001, pp. 855-862
Authors:
Koeppel, F
Riou, JF
Laoui, A
Mailliet, P
Arimondo, PB
Labit, D
Petitgenet, O
Helene, C
Mergny, JL
Citation: F. Koeppel et al., Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes, NUCL ACID R, 29(5), 2001, pp. 1087-1096
Authors:
Tamburlin-Thumin, I
Crozet, MP
Barriere, JC
Barreau, M
Riou, JF
Lavelle, F
Citation: I. Tamburlin-thumin et al., Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitors, EUR J MED C, 36(6), 2001, pp. 561-568
Authors:
Pilch, B
Allemand, E
Facompre, M
Bailly, C
Riou, JF
Soret, J
Tazi, J
Citation: B. Pilch et al., Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506, CANCER RES, 61(18), 2001, pp. 6876-6884
Authors:
Mailliet, P
Laoui, A
Bourzat, JD
Capet, M
Cheve, M
Commercon, A
Dereu, N
LeBrun, A
Martin, JP
Peyronel, JF
Salagnad, C
Thompson, F
Zucco, M
Guitton, JD
Pantel, G
Bissery, MC
Brealey, C
Lavayre, J
Lelievre, Y
Riou, JF
Vrignaud, P
Duchesne, M
Lavelle, F
Citation: P. Mailliet et al., From random screening of chemical libraries to the optimization of FPP-Competitive inhibitors of farnesyltransferase, CANC DRUG, 8, 2001, pp. 115-144
Authors:
Djiane, A
Riou, JF
Umbhauer, M
Boucaut, JC
Shi, DL
Citation: A. Djiane et al., Role of frizzled 7 in the regulation of convergent extension movements during gastrulation in Xenopus laevis, DEVELOPMENT, 127(14), 2000, pp. 3091-3100
Authors:
Umbhauer, M
Djiane, A
Goisset, C
Penzo-Mendez, A
Riou, JF
Boucaut, JC
Shi, DL
Citation: M. Umbhauer et al., The C-terminal cytoplasmic Lys-Thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling, EMBO J, 19(18), 2000, pp. 4944-4954
Authors:
Giraud, E
Luttmann, C
Lavelle, F
Riou, JF
Mailliet, P
Laoui, A
Citation: E. Giraud et al., Multivariate data analysis using D-optimal designs, partial least squares,and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitors, J MED CHEM, 43(9), 2000, pp. 1807-1816
Authors:
Umbhauer, M
Penzo-Mendez, A
Clavilier, L
Boucaut, JC
Riou, JF
Citation: M. Umbhauer et al., Signaling specificities of fibroblast growth factor receptors in early Xenopus embryo, J CELL SCI, 113(16), 2000, pp. 2865-2875
Authors:
Goossens, JF
Henichart, JP
Anizon, F
Prudhomme, M
Dugave, C
Riou, JF
Bailly, C
Citation: Jf. Goossens et al., Cellular uptake and interaction with purified membranes of rebeccamycin derivatives, EUR J PHARM, 389(2-3), 2000, pp. 141-146
Authors:
Bailly, C
Qu, XG
Anizon, F
Prudhomme, M
Riou, JF
Chaires, JB
Citation: C. Bailly et al., Enhanced binding to DNA and topoisomerase I inhibition by an analog of theantitumor antibiotic rebeccamycin containing an amino sugar residue, MOLEC PHARM, 55(2), 1999, pp. 377-385
Authors:
Moreau, P
Anizon, F
Sancelme, M
Prudhomme, M
Bailly, C
Severe, D
Riou, JF
Fabbro, D
Meyer, T
Aubertin, AM
Citation: P. Moreau et al., Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent, J MED CHEM, 42(4), 1999, pp. 584-592
Authors:
Moreau, P
Anizon, F
Sancelme, M
Prudhomme, M
Severe, D
Riou, JF
Goossens, JF
Henichart, JP
Bailly, C
Labourier, E
Tazzi, J
Fabbro, D
Meyer, T
Aubertin, AM
Citation: P. Moreau et al., Synthesis, mode of action, and biological activities of rebeccamycin bromoderivatives, J MED CHEM, 42(10), 1999, pp. 1816-1822
Authors:
Labourier, E
Riou, JF
Prudhomme, M
Carrasco, C
Bailly, C
Tazi, J
Citation: E. Labourier et al., Poisoning of topoisomerase I by an antitumor indolocarbazole drug: Stabilization of topoisomerase I-DNA covalent complexes and specific inhibition ofthe protein kinase activity, CANCER RES, 59(1), 1999, pp. 52-55